Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
12,639
-32
-0.3% -$3.09K 0.22% 59
2026
Q1
$1.22M Sell
12,671
-5
-0% -$579 0.23% 56
2025
Q4
$1.42M Hold
12,676
0.26% 52
2025
Q3
$1.49M Buy
12,676
+10
+0.1% +$1.19K 0.28% 51
2025
Q2
$1.53M Hold
12,666
0.29% 49
2025
Q1
$1.43M Buy
12,666
+16
+0.1% +$1.95K 0.3% 48
2024
Q4
$1.52M Buy
12,650
+76
+0.6% +$9.18K 0.32% 44
2024
Q3
$1.34M Buy
12,574
+10
+0.1% +$990 0.28% 45
2024
Q2
$1.19M Buy
12,564
+1,838
+17% +$191K 0.26% 46
2024
Q1
$1.19M Buy
10,726
+7
+0.1% +$653 0.26% 47
2023
Q4
$938K Buy
10,719
+9
+0.1% +$682 0.23% 54
2023
Q3
$752K Buy
10,710
+9
+0.1% +$626 0.2% 56
2023
Q2
$712K Buy
10,701
+9
+0.1% +$546 0.18% 62
2023
Q1
$625K Buy
10,692
+10
+0.1% +$573 0.17% 65
2022
Q4
$501K Buy
10,682
+15
+0.1% +$628 0.14% 70
2022
Q3
$356K Hold
10,667
0.11% 77
2022
Q2
$467K Buy
+10,667
New +$515K 0.13% 72

Other funds holding ESAB

Lincoln Capital's ESAB Position: Q2 2026 in Review

Lincoln Capital reduced its ESAB (ESAB) stake by 0.25% in Q2 2026, selling an estimated $3.09K and leaving 12,639 shares worth $1.25M. The position accounts for 0.22% of the portfolio, ranked #59.

Lincoln Capital first reported a position in ESAB in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.53M in Q2 2025. 347 funds tracked by Wall St. Rank hold ESAB as of Q2 2026.

  • Lincoln Capital held 12,639 shares of ESAB worth $1.25M as of Q2 2026.
  • Lincoln Capital sold 32 ESAB shares in Q2 2026, an estimated $3.09K.
  • ESAB made up 0.22% of Lincoln Capital's portfolio in Q2 2026, its #59 holding.
  • Lincoln Capital first reported a position in ESAB in Q2 2022 and has held it in 17 quarters since.
  • Lincoln Capital's ESAB position peaked at $1.53M in Q2 2025.
  • 347 funds tracked by Wall St. Rank held ESAB as of Q2 2026.

Based on Lincoln Capital's 13F filing for Q2 2026, filed 7 Jul 2026.